期刊文献+

多功能性纳米胶囊用于胃癌靶向磁共振成像和体内光动力治疗 被引量:2

Multifunctional Magnetic Nanocapsules for Enhanced Targeted Magnetic Resonance Imaging and Photodynamic Therapy in vivo
下载PDF
导出
摘要 目的制备负载CoFe2O4@MnFe2O4磁性纳米粒子(简称:Co@Mn MNPs)与二氢卟吩e6(简称:Ce6)的多功能纳米胶囊(简称:MNCPs),研究MNCPs对胃癌的靶向性磁共振成像与光动力治疗效果。方法采用微乳液法制备双亲性高分子聚异丁烯-铝-马来酸酐(简称:PMA)微泡包载Co@Mn MNPs与Ce6的纳米胶囊,在其表面偶联靶向分子叶酸,形成PMA-Co@Mn/Ce6-FA MNPs,制备出具有靶向性诊断与治疗的多功能纳米胶囊。检测MNCPs的表征了解其特征,并利用细胞实验探测细胞对MNCPs的利用,另外利用胃癌荷瘤裸鼠研究MNCPs在小鼠体内的磁共振成像与靶向性治疗效果。结果MNCPs粒径约(150±15)nm,呈单分散的球形,包封率为(97%),包载量约(3.1%)。细胞实验证明肿瘤细胞对MNCPs有较好的摄取,并且摄入的MNCPs对肿瘤细胞的毒性极小,还可以在633nm激光照射下对肿瘤细胞产生良好的光动力治疗(PDT)效果。动物实验证明MNCPs能增强小鼠体内肿瘤部位的磁共振成像效果,对胃癌具有显著的靶向性光动力治疗效果。结论多功能纳米胶囊对胃癌具有靶向性磁共振诊断与光动力治疗作用。 Objective To prepare multifunctional magnetic nanocapsules(MNCPs)co-loaded Co@Mn MNPs magnetic nanoparticles and photosensitizer chlorin e6(Ce6)for targeted resonance imaging(MRI)and photodynamic therapy. Methods MNCPs were synthesized by a microemulsion method to co-load Co@Mn MNPs and Ce6 by PMA,and then conjugated a target molecules(folic acid,FA)to fabricate PMA-Co@Mn/Ce6-FA MNPs(Abb:MNCPs). The biologic application of MNCPs was investigated by in vitro study. In vivo MRI and photodynamic therapy study were achieved in gastric cancer tumor-bearing nude mice. Results The characterization showed that the MNCPs exhibited an excellent dispersibility and stability with morphology of spherical capsules.The average size of MNCPs was about(150 ±15)nm and encapsulation efficiency(EE%)and % loading of Ce6 in approximately were up to(97%)and(3.1%). The cell experiment demonstrated that MNCPs showed the good biocompatibility,and possessing favorable photodynamic therapy(PDT)effect. In vivo experiment study indicated that nanocapusles exhibited an outstanding targeted magnetic resonance imaging and photodynamic therapy.Conclusion The nanocapsules can acquire the enhanced MR imaging and photodynamic therapy.
作者 张玉会 张倩 章阿敏 潘少君 洪立新 何井华 ZHANG Yuhui;ZHANG Qian;ZHANG A⁃min;PAN Shaojun;HONG Lixin;HE Jing⁃hua(Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China)
出处 《实用医学杂志》 CAS 北大核心 2019年第24期3752-3759,共8页 The Journal of Practical Medicine
基金 上海青年科技英才扬帆计划资助(编号:19YF1422300)
关键词 磁性纳米粒子 共负载磁性纳米胶囊 荧光标记 光动力治疗 磁共振成像 magnetic nanoparticles Co-loaded magnetic nanocapsules fluorescent labeling photodynamic therapy magnetic resonance imaging
  • 相关文献

参考文献3

二级参考文献28

  • 1JC Becker,C Müller-Tidow,H Serve,W Domschke,T Pohle.Role of receptor tyrosine kinases in gastric cancer: New targets for a selective therapy[J].World Journal of Gastroenterology,2006,12(21):3297-3305. 被引量:19
  • 2Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J]. The Lancet . 2010 (9742) 被引量:20
  • 3Tom Waddell,Ian Chau,David Cunningham,David Gonzalez,Alicia Frances,Clare Okines,Andrew Wotherspoon,Claire Saffery,Gary Middleton,Jonathan Wadsley,David Ferry,Wasat Mansoor,Tom Crosby,Fareeda Coxon,David Smith,Justin Waters,Timothy Iveson,Stephen Falk,Sarah Slater,Clare Peckitt,Yolanda Barbachano.Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial[J].Lancet Oncology.2013(6) 被引量:10
  • 4Florian Lordick,Yoon-Koo Kang,Hyun-Cheol Chung,Pamela Salman,Sang Cheul Oh,Gy?rgy Bodoky,Galina Kurteva,Constantin Volovat,Vladimir M Moiseyenko,Vera Gorbunova,Joon Oh Park,Akira Sawaki,Ilhan Celik,Heiko G?tte,Helena Melezínková,Markus Moehler.Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial[J].Lancet Oncology.2013(6) 被引量:14
  • 5Donald Richards,Darren M. Kocs,Alexander I. Spira,A. David McCollum,Sami Diab,Lanny I. Hecker,Allen Cohn,Feng Zhan,Lina Asmar.Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomized phase 2 study[J].European Journal of Cancer.2013 被引量:3
  • 6Terence C.Chua,Neil D.Merrett.Clinicopathologic factors associated with HER2‐positive gastric cancer and its impact on survival outcomes—A systematic review[J].Int J Cancer.2012(12) 被引量:4
  • 7Heike Grabsch,Shivan Sivakumar,Sally Gray,Helmut E. Gabbert,Wolfram Müller.HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value – conclusions from 924 cases of two independent series[J].Cellular Oncology (-).2010(1-2) 被引量:3
  • 8M. Martin-Richard,R. Gallego,C. Pericay,J. Garcia Foncillas,B. Queralt,E. Casado,J. Barriuso,V. Iranzo,I. Juez,L. Visa,E. Saigi,A. Barnadas,X. Garcia-Albeniz,J. Maurel.Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A gemcad study[J].Investigational New Drugs.2013(6) 被引量:2
  • 9Eric Van Cutsem,Sanne de Haas,Yoon-Koo Kang,Atsushi Ohtsu,Niall C. Tebbutt,Jian Ming Xu,Wei Peng Yong,Bernd Langer,Paul Delmar,Stefan J. Scherer,Manish A. Shah.Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial[J].Journal of Clinical Oncology.2012(17) 被引量:3
  • 10Yoshinari Asaoka,Tsuneo Ikenoue,Kazuhiko Koike.New targeted therapies for gastric cancer[J].Expert Opinion on Investigational Drugs.2011(5) 被引量:1

共引文献8

同被引文献8

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部